23 related articles for article (PubMed ID: 38711006)
21. Physical function as a predictor of chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer.
Lin KY; Chen PS; Lin CF
BMC Gastroenterol; 2024 May; 24(1):154. PubMed ID: 38711006
[TBL] [Abstract][Full Text] [Related]
22. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.
Stubblefield MD; McNeely ML; Alfano CM; Mayer DK
Cancer; 2012 Apr; 118(8 Suppl):2250-60. PubMed ID: 22488699
[TBL] [Abstract][Full Text] [Related]
23. Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use.
Li T; Park SB; Battaglini E; King MT; Kiernan MC; Goldstein D; Rutherford C
Qual Life Res; 2022 Nov; 31(11):3091-3107. PubMed ID: 35596913
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
